Inventor · disambiguated record
Lewis D. Pennington
Also filed as: PENNINGTON LEWIS · PENNINGTON LEWIS D · PENNINGTON LEWIS DALE
21 granted patents·17 pending applications·27 citations·filing 1997–2024
91Inventor score
Top patents by PatentIndex Score
38 records- 0191US12006330B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2021·Granted Jun 11, 2024·2 cites·113 claims
- 0290US12054495B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2022·Granted Aug 6, 2024·1 cites·51 claims
- 0388US11760747B2Substituted piperidino compounds and related methods of treatmentALKERMES INC·Filed 2021·Granted Sep 19, 2023·1 cites·121 claims
- 0486US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 0584US11542276B2Substituted macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2020·Granted Jan 3, 2023·1 cites·122 claims
- 0681US10604489B2Compounds for the treatment of painALKERMES INC·Filed 2019·Granted Mar 31, 2020·1 cites·16 claims
- 0780US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 0879US2025092063A1Substituted Macrocyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 0978US12441710B2Substituted piperidino compounds and related methods of treatmentALKERMES INC·Filed 2023·Granted Oct 14, 2025·0 cites·47 claims
- 1077US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 1174US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 1274US2024368182A1Substituted Macrocyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 1372US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 1472US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 1570US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 1669US2022033394A1Compounds for the treatment of painALKERMES INC·Filed 2021·Application pending·0 cites
- 1767US11180455B2Compounds for the treatment of painALKERMES INC·Filed 2020·Granted Nov 23, 2021·0 cites·16 claims
- 1866US2025375460A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1966US2025223260A1Substituted Pyrrolidinyl And Piperidinyl Compounds And Related Methods Of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 2066US2025230142A1Substituted Fused Bicyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 2166US2025230141A1Substituted Fused Bicyclic Compounds and Related Methods of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 2266US2025223276A1Substituted Pyrrolidinyl And Piperidinyl Compounds And Related Methods Of TreatmentALKERMES INC·Filed 2024·Application pending·0 cites
- 2364US2024174689A1Substituted carbamate macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2023·Application pending·0 cites
- 2464US2024182491A1Substituted fused bicyclic macrocyclic compounds and related methods of treatmentALKERMES INC·Filed 2023·Application pending·0 cites
- 2563US2025214969A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2663US2024124485A1Substituted amide macrocyclic compounds with orexin-2 receptor agonist activityALKERMES INC·Filed 2023·Application pending·0 cites
- 2762US2024173419A1Cdk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2862US2025205342A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2961US10975099B2Thiophene compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Apr 13, 2021·0 cites·17 claims
- 3060US10807995B2Thienothiophene compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 20, 2020·0 cites·13 claims
- 3160US2025051338A1Tyk2 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3259US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 3356US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 3447US10799496B2Naphthylenyl compounds for long-acting injectable compositions and related methodsALKERMES PHARMA IRELAND LTD·Filed 2019·Granted Oct 13, 2020·0 cites·18 claims
- 3543US8163766B2Beta-secretase modulators and methods of useZHONG WENGE·Filed 2010·Granted Apr 24, 2012·0 cites·10 claims
- 3640US2014155415A1Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetesBARTBERGER MICHAEL DAVID·Filed 2012·Application pending·0 cites
- 3734US5998442ABenzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemiaLILLY CO ELI·Filed 1997·Granted Dec 7, 1999·3 cites·28 claims
- 3830US8431563B2Compounds that interact with glucokinase regulatory protein for the treatment of diabetesASHTON KATE·Filed 2011·Granted Apr 30, 2013·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Lewis D. Pennington files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →